An interchangeable ELISA for cytomegalovirus antigen and antibody.
about
Antiherpesvirus activity and mechanism of action of indolo-(2,3-b)quinoxaline and analogsAcyclic guanosine analogs as inhibitors of human cytomegalovirusStudies of cytomegalovirus infection in renal allograft recipients.Activity of the cytomegalovirus genome in the presence of PPi analogs.Enhancive and suppressive effects of cytomegalovirus on human lymphocyte responses in vitroCharacteristics of the specific cell-mediated immune response in human immunodeficiency virus infectionVirus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections.Variations in the cytomegalovirus major immediate-early gene found by direct genomic sequencing.Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections.Effect of primary Epstein-Barr virus infection on human herpesvirus 6, cytomegalovirus, and measles virus immunoglobulin G titers.Evaluation of a synthetic-peptide enzyme-linked immunosorbent assay for immunoglobulin M to human parvovirus B19Antibody responses to synthetic peptides from cytomegalovirus phosphoprotein 150.Enzyme-linked immunosorbent assay for detection of equine infectious anemia virus p26 antigen and antibodyVirus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infectionsFiberoptic bronchoscopy for diagnosis of opportunistic pulmonary infections after bone marrow transplantation.Cytomegalovirus glycoprotein B-specific antibody analysis using electrochemiluminescence detection-based techniques.Polymerase chain reaction assay for detection of human cytomegalovirus.Detection of immunoglobulin M and G antibodies against cytomegalovirus early and late antigens by enzyme-linked immunosorbent assay.Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients.Lethal disseminated adenovirus type 1 infection in a patient with chronic lymphocytic leukemia.Development of a quadriplex polymerase chain reaction for human cytomegalovirus detection.Cytomegalovirus-infected adherent cells interact synergistically and antagonistically with Staphylococcus aureus protein A in vitro.Cytomegalovirus-seropositive children show inhibition of in vitro EBV infection that is associated with CD8+CD57+ T cell enrichment and IFN-γ.Correlation between cytomegalovirus and toxoplasma gondii serology and lymphocyte phenotypes in peripheral blood and cord blood.Reduced risk of recurrent leukaemia in bone marrow transplant recipients after cytomegalovirus infection.Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients.Polyclonal antibody secretion during acute graft-versus-host disease.Evaluation by immune scanning electron microscopy of foscarnet treatment of cytomegalovirus infection in patients with renal transplants.Clinical use of immunohistopathologic methods for the diagnosis of cytomegalovirus hepatitis in human liver allograft biopsy specimens.Diagnosis of cytomegalovirus infections using polymerase chain reaction, virus isolation and serology.Strong donor mononuclear cell reactivity for herpes simplex virus (HSV) antigen in HSV immune donors combined with recipient seropositivity for HSV is associated with acute graft-versus-host disease.Management of pregnant women with contagious infections at delivery.Congenital CMV infection: prevalence in newborns and the impact on hearing deficit.
P2860
Q28360008-33183881-B523-4E4A-A32E-0DA5FDBBC58AQ28360560-1CD64ECA-B86B-4B1B-80BA-72B97370F319Q33476864-6E22F608-23EF-47AE-A2C7-65F01114417EQ36855004-B235C2DB-32C8-4EE2-A96F-1A9B6BE28C00Q36863680-043F2854-2782-40F9-9D19-2BE9EFC7D0A5Q36889122-D78DD769-E7BB-4E63-B6E4-D38A62E758E1Q37104042-26871F9F-D6E5-402E-BB4B-FB4E85D9B298Q37119074-20D201AE-E615-41B8-AB0E-ED68E7E4364CQ37124499-820CE038-5B31-4D33-BE56-A40903008EA0Q37225916-83F31FF2-4D5C-4C0A-BBC3-1A09CB63C8E9Q37239480-39611228-1085-48D8-AB95-D4FF87F98457Q37248802-8116C9C7-68FD-4F3E-B0C1-298E4BA72E8BQ37261668-C983196A-83B7-4BE9-843F-BA5A7E846AB1Q37266565-C81E7E94-A8C5-4107-BEF4-081ACFECE2DCQ38727381-5525815F-5C9C-46B7-8E72-F8E734678436Q39811091-C88F158C-2F88-4C56-9563-0B742FEF65B2Q40199674-B58D872E-2F71-4BD7-8680-14297C1631DCQ40219666-A3B09C9C-D083-4AB9-A9D9-104CB8746910Q40741038-7C470E9C-4741-4CF9-8AFC-7EB484223302Q40766969-8B5F8A70-2837-4989-9170-D63D79C8B5B8Q40954786-BAA100DC-B9DD-4AAD-9825-E1BDD973E2E3Q41786208-044F92B1-C1F5-4AD6-B32B-66AABEF980F2Q42261208-340A010A-0DC2-4AC6-AA4E-85E34BC0A6A5Q43454741-E0537163-6B5A-44BD-9AC1-EED8547E5AA8Q43714651-6B029966-67EC-4850-B74B-B908A95573B4Q43797919-7003F8EE-AF47-49AC-B1E8-428D262289A8Q44189942-065CC33C-7EB8-4530-8BC2-07FFAB496253Q44662429-FB2E01D2-D764-440A-9E54-FCB245639146Q44985842-4DD4B1B4-B90B-4E91-9AC8-A72202AE79C5Q45774759-E4364316-1A59-46F2-91C5-5E87146FCB9FQ45863819-74B69B40-3E4A-4BAB-9961-67FF9988A294Q47690742-FBCF0755-5470-4CBD-B259-2E07D0E5A523Q50450202-DF846772-3EF8-48AF-A002-4F3F2A81CE7F
P2860
An interchangeable ELISA for cytomegalovirus antigen and antibody.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh-hant
name
An interchangeable ELISA for cytomegalovirus antigen and antibody.
@en
An interchangeable ELISA for cytomegalovirus antigen and antibody.
@nl
type
label
An interchangeable ELISA for cytomegalovirus antigen and antibody.
@en
An interchangeable ELISA for cytomegalovirus antigen and antibody.
@nl
prefLabel
An interchangeable ELISA for cytomegalovirus antigen and antibody.
@en
An interchangeable ELISA for cytomegalovirus antigen and antibody.
@nl
P1476
An interchangeable ELISA for cytomegalovirus antigen and antibody.
@en
P2093
Sundqvist VA
P304
P356
10.1016/0166-0934(81)90029-X
P577
1981-04-01T00:00:00Z